SYNTHESIS AND DNA-CLEAVING ACTIVITY
497
14. Diple, A, Michejda, C.J, and Weisburger, E.K, in Metab-
olism of Chemical Carcinogenes Part 1, Grunberg, D.
and Goff, S., Eds., New York: Academic, 1987.
tion [48] (containing 0.1% Bromophenol Blue,
150 mM EDTA, 1% SDS in 2 mM Tris, 1 mM acetate,
pH 8) was added into each well before loading (in dark)
onto 1% Agarose gel containing an aqueous Ethidium
Bromide solution (10 mg/ml). The gel was electro-
phoresed for 2 h at 120 V in 1 × TAE (40 mM Tris ace-
tate, 1 mM EDTA, pH 8.2) buffer. Incubations with are-
nediazonium salts were carried out for 2 h using the fol-
lowing final concentrations: 31.53 nM DNA, 0.375 mM
arenediazonium salt, and 0.775 mM copper chloride.
DNA in gel was analyzed with BioRad Gel Doc XR
Gel-Documentation system. The amount of supercoiled
form I DNA (sc-DNA), the relaxed open circular form
II DNA (oc-DNA), and linear form III DNA (l-DNA)
were quantified by the intensity of the bands with
Quantity One programme (version 4.5.2, BioRad Co.).
15. Gali, C., Chem. Rev., 1988, vol. 88, pp. 765–792.
16. Chin, A., Hung, M.-H., and Stock, L.M., J.Org. Chem,
1981, vol. 46, pp. 2203–2207.
17. Hung, M.-H. and Stock, L.M., J. Org. Chem., 1982,
vol. 47, pp. 448–453.
18. Gannett, P.M., Powell, J.H., Rao, R., Shi, X., Lawson, T.,
Kolar, K., and Toth, B., Chem. Res. Toxicol., 1999,
vol. 12, pp. 297–304.
19. Stiborova, M., Asfaw, B., Frei, E., Schemeiser, H.H., and
Weiessler, M., Chem. Res. Toxicol., 1995, vol. 8,
pp. 489–498.
20. Berh, J.P., J. Chem. Soc. Chem. Commun., 1989,
pp. 101–103.
The percentage of net DNA cleavage was calculated
by the following equation: [(Form II)s + (Form III)s] –
[(Form II)c + (Form III)c]. The subscripts ‘s’ and ‘c’
refer to as the samples and controls, respectively [51].
21. Griffiths, J. and Murphy, J.A., J. Chem. Soc. Chem.
Commun., 1992, pp. 24–26.
22. Kato, T., Kojima, K., and Hiramoto, K., Mutat. Res.,
1992, vol. 268, pp. 105–114.
23. Hazlewood, C., Davies, M.J., Gilbert, B.C., and
Packer, J.E., J. Chem. Soc., Perkin Trans. 2, 1995,
pp. 2167–2174.
ACKNOWLEDGMENTS
24. Hiramoto, K., Kaku, M., Kato, T., and Kikugawa, K.,
˙
We thank Dr. Ebru I nce Yılmaz for assistance with
Chem. Biol. Interact., 1995, vol. 94, pp. 21–36.
plasmid DNA purification, and Generous financial sup-
port by Dicle University Research Foundation
(DÜAPK, Project numbers: 02-FF-10 and 03-FF-63).
˙
25. Kizil, M., Yilmaz, E.I., Pirinccioglu, N., and
Aytekin, C., Turk J. Chem., 2003, vol. 27, pp. 539–544.
26. Gannett, P.M., Ye, J., Ding, M., Powell, J., Zhang, Y.,
Darian, E., and Daft, J., Chem. Res. Toxicol., 2000,
vol. 10, pp. 1020–1027.
27. Zollinger, H., Diazo Chemistry: Aromatic and Heteroar-
omatic Compounds, Vol. 1, New York: Wiley, 1994.
28. Bravo Diaz, C. and Gonzalez, Romero E., Curr. Topics
Colloid Interface Sci., 2001, vol. 4, p. 58.
29. Quintero, B. Cabeza, M.C., Martinez, Puentedura, M.I.,
Gutierrez, P., Martinez, De Ias Parras, P.J., Llopis, L.,
and Zarzuelo, A., Ars Pharm., 2003, vol. 44, pp. 239–
255.
REFERENCES
1. Preussman, R., Ivankovic, S., Landschuttz, C., Gimmy, J.,
Flohr, E., and Grisebach, U., Z. Krebsforsch., 1974,
vol. 81, pp. 285–310.
2. Gold, B. and Salmasi, S., Cancer Lett., 1982, vol. 15,
pp. 289–300.
3. Ames, B.N., Magaw, R., and Gold, L.S., Science, 1987,
vol. 236, pp. 271–280.
4. Kikugawa, K., Kato, T., and Takeda, Y., Mutat. Res.,
1987, vol. 172, pp. 35–43.
30. Dornberger, K., Ihn, W., Schade, W., Tresselt, D.,
Zureck, A., and Radics, I., Tetrahedron Lett., 1986,
vol. 27, pp. 559–560.
5. Kikugawa, K. and Kato, T., Food Chem. Toxicol., 1988,
vol. 26, pp. 209–214.
31. Kikugawa, K.., Kato, T., and Kojima, K., Mutat. Res.,
6. Ohsima, H., Furihata, C., Matsushima, T., and Bartsch, H.,
1992, vol. 268, pp. 65–75.
Food Chem. Toxicol., 1989, vol. 27, pp. 193–203.
32. Toth, B., Patil, K., Taylor, J., Stessman, C., and Gannett, P.,
7. Lawson, T., Gannett, P.M., Yau, W.M., Dalal, N.S., and
Toth, B., J. Agric. Food Chem., 1995, vol. 43, pp. 2627–
2635.
8. Stiborova, M., Hansikova, H., Schmeiser, H.H., and
Frei, E., Gen. Physiol. Biophys, 1997, vol. 16,
pp. 285–300.
In Vivo, 1989, vol. 3, pp. 301–306.
33. Levenberg, B., Biochim. Biophys. Acta, 1962, vol. 63,
pp. 212–214.
34. Stiborova, M., Asfaw, B., Anzenbacher, P., Leseticky, L.,
and Hodek, P., Cancer Lett., 1988, vol. 40, pp. 319–326.
9. Toth, B. and Gannett, P., Mycopathologia, 1993,
35. Stiborova, M., Asfaw, B., Anzenbacher, P., and Hodek, P.,
vol. 124, pp. 73–77.
Cancer Lett., 1988, vol. 40, pp. 327–333.
10. Toth, B., Patil, K., Erickson, J., and Gannett, P., In Vivo,
36. Toth, B., Patil, K., and Jae, H., Cancer Res., 1981,
1998, vol. 12, pp. 379–382.
vol. 41, pp. 2444–2449.
11. Toth, B., Patil, K., Erickson, J., and Gannett, P., In Vivo,
37. Toth, B., Nagel, D., and Ross, A., Br. J. Cancer, 1982,
1999, vol. 13, pp. 125–128.
vol. 46, pp. 417–422.
12. Toth, B., In Vivo, 2000, vol. 14, pp. 299–319.
38. Gannett, P.M., Lawson, T., Miller, M., Thakkar, D.D.,
Lord, J.W., Yau, W.-M., and Toth, B., Chem. Biol. Inter-
act., 1996, vol. 101, pp. 149–164.
13. Koepke, S.R., Kroeger-Koepke, M.B., and Michejda, C.,
Chem. Res. Toxicol., 1990, vol. 3, pp. 17–20.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY Vol. 34 No. 4 2008